Skip to main content
. 2012 Dec 6;52(1):22–26. doi: 10.3164/jcbn.12-40

Table 2.

Changes in metabolic variables after six weeks, as compared with basal levels in the group of study

S-dAGEs L-dAGEs T/Z* p
Biochemical data
 Glucose (mg/dl) 4.55 ± 35.6 –18 ± 56.7 –1.21 0.24
 Total-cholesterol (mg/dl) –9.0 ± 44.9 5.7 ± 43.3 0.84 0.41
 Triglycerides (mg/dl) –3.7 ± 80.2 5.4 ± 59.0 0.33 0.74
 HDL-cholesterol (mg/dl) –4.2 ± 10.3 –2.5 ± 7.4 0.48 0.64
 HbA1c (%) –0.11 ± 1.9 0.19 ± 1.3 0.46 0.65
Metabolic markers
 Fluorescent serum AGEs  (arbitrary units) 0.68 ± 2.1 0.29 ± 1.3 –0.57 0.57
 Malondialdehyde (µmol/l) 2.0 ± 2.61 –0.83 ± 2.0 –3.12 <0.005
 PCR (mg/l) –1.21 ± 5.5 –1.69 ± 5.4 0.23 0.82
 TNF-α (pg/ml) 12.5 ± 14.7 –18.36 ± 17.1 –4.92 <0.00001
 Insulin (µU/ml) –7.0 ± 17.0 –4.81 ± 7.3 –0.67 0.5
 HOMA-IR –2.5 ± 6.1 –2.29 ± 3.7 0.13 0.89
Dietary variables
 Kilocal/day –222 ± 415.1 –110 ± 307 0.78 0.44
 Carbohydrates (g/day) –32.0 ± 73.2 –23.6 ± 61.9 0.3 0.76
 Fats (g/day) –6.1 ± 16.2 0.13 ± 20.6 0.85 0.4
 Proteins (g/day) –9.6 ± 14.6 –3.63 ± 22.0 0.82 0.42
 dAGEs (as CML, KU/day) 2304 ± 4169 –4990 ± 3380 –4.9 <0.00005

*Mann-Whitney U test.

HHS Vulnerability Disclosure